Min-chuan Huang

TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter-mediated doxorubicin resistance.

C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter-mediated doxorubicin resistance.

Journal: The Journal of pathology
Published: July 02, 2024

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC.

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC.

Journal: Oncogenesis
Published: May 24, 2023

Targeting tumor O-glycosylation modulates cancer-immune-cell crosstalk and enhances anti-PD-1 immunotherapy in head and neck cancer.

Targeting tumor O-glycosylation modulates cancer-immune-cell crosstalk and enhances anti-PD-1 immunotherapy in head and neck cancer.

Journal: Molecular oncology
Published: January 02, 2023

Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer.

Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer.

Journal: Molecular cancer research : MCR
Published: November 14, 2022

GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL.

GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL.

Journal: Molecular oncology
Published: May 26, 2022

Endolysosomal cation channels point the way towards precision medicine of cancer and infectious diseases.

Endolysosomal cation channels point the way towards precision medicine of cancer and infectious diseases.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 22, 2021

C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.

C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.

Journal: Oncogenesis
Published: October 23, 2021

Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153.

Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153.

Journal: Bone research
Published: August 05, 2021

Anti-C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer.

Anti-C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer.

Journal: The Laryngoscope
Published: January 09, 2020

The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.

The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.

Journal: American journal of cancer research
Published: April 12, 2018

C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.

C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 13, 2017

GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.

GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.

Journal: Oncotarget
Published: September 24, 2016
Showing 1-12 of 34

Last Updated: 09/26/2026